Multiplikator Forward P/S: Treace Medical Concepts, Inc. (TMCI)
The potential of Treace Medical Concepts (TMCI) is based on physician training for the Lapiplasty system and FDA approvals. The trend in expected P/S confirms this trajectory, with the latest value recorded as 1.70. However, patent protection and stringent qualification requirements create high barriers to entry. At the same time, the rapid market capture via innovative foot correction methods carries the risk of overpaying for future sales.
Ringkesan rincian data analitis Treace Corp (TMCI)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- statistik nilai buku emiten:
- data utang lan likuiditas:
Total Utang marang Modal Treace Medical Concepts|TMCI - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Treace Medical Concepts|TMCI - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Treace Corp|TMCI - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Treace Medical Concepts|Rasio cepet treace.com
- rincian asil keuangan lan kelipatan valuasi:
TMCI - Penghasilan resik perusahaan|Bathi sing dikarepake Treace Medical Concepts|TMCI - Rasio kapitalisasi marang bathi resik|Prakiraan rega marang bathi Treace Medical|TMCI - Pangali PEG|Pangali EV/EBITDA Treace Corp|TMCI - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Treace Medical Concepts|TMCI - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan treace.com|TMCI - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Treace Medical Concepts
- indikator dodolan lan pendapatan:
Analisis fundamental perusahaan:TMCI (Treace Medical Concepts, Inc.)
This indicator compares the current market value of Treace Medical Concepts (TMCI) with projected revenue, allowing for an assessment of the premium paid for future cash flows. Analyzing the forward P/S ratio is critical to understanding the scalability of Lapiplasty disposable titanium implant sales, as this multiple reflects the market consensus regarding the expansion rate of the company's recurring margin.
Karo sapa Treace Medical Concepts saingan
Rasio rega marang prakiraan pendapatan Boston Scientific Corporation BSX|EW - Multiplikator forward rega marang pendapatan|ResMed Corp - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Insulet Inc.|ZBH: Multiplikator Forward P/S|Kapitalisasi marang prakiraan pendapatan COO|ALGN (Align Technology) - Multiplikator Forward P/S|Globus Medical Inc (GMED) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S TMDX|Multiplikator forward rega marang pendapatan Alphatec Corp ATEC|Multiplikator Forward P/S AORT (Artivion, Inc.)|Multiplikator Forward P/S enovis.com ENOV|IART - Rasio rega marang prakiraan pendapatan|ESTA: Rasio rega marang prakiraan pendapatan|BBNX (Beta Bionics Corp) - Multiplikator forward rega marang pendapatan|IRADIMED Inc. - Rega forward marang dodolan|EMBC (Embecta Corp.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep tandemdiabetes.com TNDM|Rasio rega marang prakiraan pendapatan Axogen (AXGN)|SI-BONE Inc (SIBN) - Prakiraan rega marang pendapatan|Orthofix International - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Bioventus Global BVS|OrthoPediatrics Inc. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake blade.com SRTA|Carlsmed (CARL) - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan RXST (RxSight Inc)|Rasio rega marang prakiraan pendapatan ClearPoint Neuro Inc.|Multiplikator forward rega marang pendapatan Stereotaxis Corporation (STXS)|Multiplikator Forward P/S STIM|SGHT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Rasio rega marang prakiraan pendapatan Orchestra BioMed, Inc. OBIO|ANIK: Kapitalisasi marang prakiraan pendapatan|NSPR: Multiplikator forward rega marang pendapatan|Jin Medical International - Rasio rega marang pendapatan sing dikarepake|VANI (vivani.com) - Multiplikator forward rega marang pendapatan|XTNT: Rasio rega marang pendapatan sing dikarepake|Rasio rega marang prakiraan pendapatan NeuroOne Medical Technologies Corporation|MODD: Rega forward marang dodolan|Multiplikator Forward P/S MYO|COCH - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S VVOS (Vivos Therapeutics)|Multiplikator Forward P/S envveno.com NVNO|SINTX Technologies - Multiplikator Forward P/S|Tenon Medical Inc. (TNON) - Multiplikator forward rega marang pendapatan|LFWD: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Autonomix Medical (AMIX)|Multiplikator forward rega marang pendapatan IVF|BBLG: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Axonics (AXNX)|Multiplikator forward rega marang pendapatan BIOLASE Inc. BIOL|Multiplikator Forward P/S DYNT (Dynatronics)|Paragon 28 Inc. (FNA) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|INVO Bio - Multiplikator Forward P/S
